The Motley Fool

What can Google do that GlaxoSmithKline plc cannot?

The UK medical giant GlaxoSmithKline (LSE: GSK) has announced a new partnership with the Alphabet life science’s division Verily to create a UK based start-up called Galvani Bioelectronics. How will they work together?

Sign up for FREE issues of The Motley Fool Collective. Do you want straightforward views on what’s happening with the stock market, direct to your inbox? Help yourself with our FREE email newsletter designed to help you protect and grow your portfolio. Click here to get started now — it’s FREE!

Our top analysts have highlighted five shares in the FTSE 100 in our special free report "5 Shares To Retire On". To find out the names of the shares and the reasons behind their inclusion, simply click here to view it immediately with no obligations whatsoever.